1. Supplementary Figure 1 Shiota et al.
0.0
0.2
0.4
0.6
0.8
1.0 P r o g e s i n - f u v a l t 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Duration (years)
Testosterone (quartile) Q1 Q2 Q3 Q4
P = 0.25
No.
at risk 1Q 24 15 7 4 2 1 2Q 9 6 3Q 13 3 4Q 10 8 5 B
0.0
0.2
0.4
0.6
0.8
1.0 P r o g e s i n - f u v a l t 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Duration (years)
Testosterone (quartile) Q1
Q2-Q4
P = 0.70
No.
at risk 1Q 24 15 7 4 2 1
2Q-4Q 72 32 20 13 3
Supplementary Figure 1. (A) PFS in patients stratified by serum testosterone level quartile (Q1, Q2, Q3, and Q4). (B) PFS in patients stratified by the 1st quartile (Q1) and 2nd to 4th quartiles (Q2–Q4) of serum testosterone levels.